Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4761167
Max Phase: Preclinical
Molecular Formula: C52H67N8NaO16S
Molecular Weight: 1093.22
Molecule Type: Unknown
Associated Items:
ID: ALA4761167
Max Phase: Preclinical
Molecular Formula: C52H67N8NaO16S
Molecular Weight: 1093.22
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCCC[C@H]1SC[C@H]2NC(=O)N[C@H]21)NCCOCCOCCOCCn1cc(-c2ccc(CO[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(=O)CO)[C@H]([C@H](O)[C@H](O)CNC(=O)Cc4ccc(-c5ccc(O)cc5)cc4)O3)cc2)nn1.[Na+]
Standard InChI: InChI=1S/C52H68N8O16S.Na/c61-29-45(67)56-47-40(63)26-52(50(69)70,76-49(47)48(68)41(64)27-54-44(66)25-32-5-9-34(10-6-32)35-13-15-37(62)16-14-35)75-30-33-7-11-36(12-8-33)38-28-60(59-58-38)18-20-73-22-24-74-23-21-72-19-17-53-43(65)4-2-1-3-42-46-39(31-77-42)55-51(71)57-46;/h5-16,28,39-42,46-49,61-64,68H,1-4,17-27,29-31H2,(H,53,65)(H,54,66)(H,56,67)(H,69,70)(H2,55,57,71);/q;+1/p-1/t39-,40+,41-,42-,46-,47-,48-,49-,52-;/m1./s1
Standard InChI Key: GPESDGHSVYDKPO-AFUUWIHMSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1093.22 | Molecular Weight (Monoisotopic): 1092.4474 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Abdu-Allah HHM,Wu SC,Lin CH,Tseng YY. (2020) Design, synthesis and molecular docking study of α-triazolylsialosides as non-hydrolyzable and potent CD22 ligands., 208 [PMID:32942185] [10.1016/j.ejmech.2020.112707] |
Source(1):